文献速递神经免疫认知障碍与痴呆

已发表的参考资源对多发性硬化患者神经丝轻链水平判定的一致性

Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis.
PubMed 文献 · Neurology · 2023-12-04

本研究比较6种已发表参考资源对多发性硬化(MS)患者血清神经丝轻链(NfL)判读的一致性,共分析6687例患者的12855次检测。不同参考资源判定NfL升高的比例从3.7%到30.9%不等,6种资源间kappa系数为0.576(95%CI 0.571-0.580),一致性中等。作者认为NfL判读可能因参考资源选择而显著不同,临界升高值应谨慎解读。

要点

  • 6种参考资源判定NfL升高的比例从3.7%到30.9%不等。
  • 6种参考资源间kappa系数为0.576(95%CI 0.571-0.580),一致性中等。
  • 不同参考资源得出的Z评分Spearman相关系数超过0.90,但一致性系数较低(0.72至0.89)。

核心结论

  • 血液NfL值的解读可能因参考资源的选择而显著不同。
  • 临界升高值应谨慎解读,未来研究应关注标准化NfL检测与报告、更好表征混杂/影响因素以及明确NfL对疾病特异性结局的预测性能。

研究设计与样本

  • 使用6种已发表参考资源对多发性硬化伙伴推进技术与健康解决方案(MS PATHS)网络中参与者的NfL进行分类(升高或正常)并推导年龄特异性NfL Z评分。
  • 共纳入6687例多发性硬化患者的12855次 visit 的NfL检测数据(每位个体中位数2个样本,范围1-7)。
  • 若NfL值超过年龄特异性参考范围的>95百分位(即Z评分>1.645),则分类为升高。
  • 6种参考资源中有4种可推导年龄特异性NfL Z评分。

主要发现

  • 参与者平均±标准差年龄为47.1±11.7岁,72.1%为女性,疾病病程为15.0±10.6年,体重指数为28.6±6.9 kg/m2,血清NfL为12.87±12.86 pg/mL。
  • 根据参考资源的选择,判定为升高的NfL检测比例从3.7%到30.9%不等。
  • 6种参考资源的kappa系数为0.576(95%CI 0.571-0.580),表明一致性中等。
  • 不同参考资源得出的Z评分间Spearman相关系数超过0.90,但一致性系数较低,范围为0.72至0.89。

关键数值与推荐

  • NfL值超过年龄特异性参考范围的>95百分位(即Z评分>1.645)时分类为升高。
  • 6种参考资源间kappa系数为0.576(95%CI 0.571-0.580),一致性中等。
  • 不同参考资源Z评分的Spearman相关系数超过0.90,一致性系数为0.72至0.89。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the agreement between published reference resources for neurofilament light chain (NfL) applied to a large population of people with multiple sclerosis (MS). METHODS: Six published reference resources were used to classify NfL in participants in the Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) network as elevated or normal and to derive age-specific NfL Z-scores. NfL values were classified as elevated if they exceeded the >95th percentile (i.e., Z-score >1.645) of the age-specific reference range. Furthermore, age-specific NfL Z-scores could be derived for 4 of 6 reference resources. RESULTS: NfL measurements were assessed from 12,855 visits of 6,687 people with MS (median 2 samples per individual [range 1-7]). The mean ± SD age was 47.1 ± 11.7 years, 72.1% of participants were female, disease duration was 15.0 ± 10.6 years, body mass index was 28.6 ± 6.9 kg/m2, and serum NfL was 12.87 ± 12.86 pg/mL. Depending on the selection of the reference resource, the proportion of NfL measurements classified as elevated varied from 3.7% to 30.9%. The kappa coefficient across the 6 reference resources used was 0.576 (95% CI 0.571-0.580) indicating moderate agreement. Spearman correlations between Z-scores derived from the various reference resources exceeded 0.90; however, concordance coefficients were lower, ranging from 0.72 to 0.89. DISCUSSION: Interpretation of blood NfL values may vary markedly depending on the selection of the reference resource. Borderline elevated values should be interpreted with caution, and future studies should focus on standardizing NfL measurement and reporting across laboratories/platforms, better characterizing the effects of confounding/influencing factors, and defining the performance of NfL (including as part of multimodal predictive algorithms) for prediction of disease-specific outcomes.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Sotirchos ES, Hu C, Smith MD, et al. Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis. Neurology. 2023. PMID: 37816633. doi:10.1212/WNL.0000000000207957

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。